On September 27, 2026, Senate Majority Leader Chuck Schumer sent a formal letter to the FDA demanding a comprehensive investigation into the flood of illicit, Chinese-manufactured e-cigarettes entering the U.S. market. He gave the agency 30 days — until October 27, 2026 — to produce a formal report detailing enforcement actions, customs interdiction efforts, and a plan to address what he called a "public health crisis hiding in plain sight."
In plain terms: The most powerful Senator in the chamber just put the FDA on a clock. He's not introducing new legislation — he's demanding the FDA use its existing authority more aggressively. The 30-day deadline means we'll see the agency's response before the November elections, making this a politically charged moment for tobacco enforcement.
The data Schumer cited is damning. According to market intelligence cited in his letter, approximately 70% of all e-cigarette sales in the United States come from unauthorized products that have never received FDA marketing authorization. For disposable e-cigarettes — the format most popular among teens — that figure rises to 97%.
This isn't a new problem, but the political pressure is intensifying. The FDA's seize-and-destroy enforcement operation (Operation Red Mist) seized 18 million units and $175 million in product earlier in 2026. But Schumer's letter suggests that enforcement isn't keeping pace with the scale of the illicit market.
